BacTech Environmental Corporation (“BacTech” or the “Company”) (CSE:BAC, US-OTC:BCCEF)

today announced that it has taken initial steps to establish a bioleach project in Ecuador that

will treat high arsenic concentrates produced in the country.

A visit that coincided with the annual Expominas Convention in Quito in late April provided an

opportunity for management of BacTech to identify and secure arsenopyrite concentrate

samples for bioleach work to be conducted at Laurentian University under the direction of the

Company’s Dr. Paul Miller. It is anticipated that samples totalling approximately 35 kg of

arsenopyrite concentrate will be secured from 2 mines in an area that historically has produced

very high levels of arsenic associated with gold. The sample collection should take place in early

June and will be carried out by MSA Labs of Vancouver, Canada. MSA will also be tasked with

providing assays for the samples as well as a 35 element ICP scan for metallurgical data. A

standard bioleach test program will take 6 months to complete.

In Ecuador, high arsenic concentrates are sold mostly to buyers in Asia with severe penalties

applied to the sales price. It is not uncommon for concentrates with up to 15% arsenic to be

sold for as little as 50% of the gold content with no compensation for any related silver or

copper. Bioleaching provides a hydrometallurgical solution to processing these “dirty”

concentrates, as any associated arsenic is produced as a ferric arsenate, meeting United States

Environmental Protection Agency (“EPA”) or local equivalent environmental regulations for


Producers of high arsenic concentrates are constantly searching for an inexpensive means of

processing their material, but this has proven to be very difficult given the global restrictions on

treating concentrates high in arsenic. Smelter and/or roasters have severe limitations on the

amount of arsenic that can be burned as the off-gas is a very toxic arsenic trioxide which is

collected and stored. The Giant Mine in Yellowknife, Canada is a good example of the long-term

effects of burning arsenopyrite as there remains some 250,000 tonnes of this material stored

underground waiting for a disposal solution. In this instance the estimated cost to rectify the

mine site and the associated arsenic is estimated to cost the taxpayers of Canada $1 billion.

Over the past year, BacTech and Laurentian University have run 2, separate bioleach test

programs on 3 different types of material from Ecuador, namely ore, concentrate and tailings.

Results of the first program confirmed the ability of bioleaching to produce and stabilize over

99% of the contained arsenic in the material. Arsenic values in several of the samples reached

as high as 17%. The second test program was designed to focus on different pulp densities

which in turn will provide expected gold percentage recovery. These final results will be

released shortly pending assay by an independent laboratory. The upcoming bioleach work will

focus on concentrate from 2 separate mines from the same area. Should the test work results

conform to historic results on similar materials treated by BacTech, the Company will move to

negotiate a secure feed by paying a higher price per tonne of concentrate than what is received

today. The material will be the base feed for what is initially expected to be a 40 tonne per day

bioleach plant in the area.

A local bioleach circuit would provide many benefits to Ecuador and the affected area of the

plant. Instead of exporting raw material for processing, the plant will allow for local job

creation, increased taxes generated locally and federally and of course, the knowledge that

arsenic associated with gold production in the area is being dealt with in a sustainable manner.

There are many arsenic gold mines in the area, and it is expected that over time the amount of

arsenopyrite concentrate that is produced locally will continue to grow allowing for modular

expansion of the original bioleach plant to handle the increase in feeds.

“We are very excited about starting this new venture. The support we have received from the

Ministry of the Environment has been great as it helps to open doors for us in the country.

These two particular mines are part of a much larger community of mines in the area. It is not

unreasonable to expect that if we build the plant, that others will come forward to supply

concentrates for local processing. The key is getting the commitment to a secure feed so we

can finance the project,” commented Ross Orr, President and CEO of BacTech.

Company Overview

The Telamayu project involves the environmental remediation of the “Antiguo” tailings with an

option on the larger “Nuevo” tailings, both situated at the Telamayu Mill site near the town of

Atocha in the Department of Potosi, Bolivia.

A second project entails BacTech investigating the use of bioleach processing to treat historic

arsenic tailings and arsenopyrite concentrates produced in the Ponce Enriquez area of Southern


Finally, BacTech has recently agreed to participate with a group looking to reprocess the

Arsenic Stockpile in Snow Lake, Manitoba.

For further information contact: Ross Orr, President & CEO, BacTech Environmental

Corporation/ 416-813-0303 ext. 222, Cell 416-346-5529 and


Robin Cook, Investor Relations: 416-809-1738, Email:

Follow us on:






Special Note Regarding Forward-Looking Statements

This news release contains “forward-looking information”, which may include, but is not limited

to, statements with respect to future tailings sites, sampling or other investigations of tailing

sites, the Company’s ability to make use of infrastructure around tailings sites or operating

performance of the Company and its projects. Often, but not always, forward-looking statements

can be identified using words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”,

“estimates”, “forecasts”, “intends”, “anticipates”, or believes” or variations (including negative

variations) of such words and phrases, or state that certain actions, events or results “may”,

“could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements

involve known and unknown risks, uncertainties and other factors which may cause the actual

results, performance or achievements of the Company to be materially different from any future

results, performance or achievements expressed or implied by the forward-looking statements.

Forward-looking statements contained herein are made as of the date of this news release and the

Company disclaims, other than as required by law, any obligation to update any forward-looking

statements whether because of new information, results, future events, circumstances, or if

management’s estimates or opinions should change, or otherwise. There can be no assurance that

forward-looking statements will prove to be accurate, as actual results and future events could

differ materially from those anticipated in such statements. Accordingly, the reader is cautioned

not to place undue reliance on forward-looking statements.

Shares outstanding: 96,903,756

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility

for the adequacy or the accuracy of the contents of this release.